홈 카테고리 맞춤형시장조사 국제컨퍼런스 글로벌 파트너 메일링 서비스 회사소개회사소개 Contact Us
English Japaness Chinese
Home > 시장보고서 > 파머슈티컬 > 비처방 의약품 > OTC Healthcare in Poland
카테고리
파머슈티컬 (4931)
감염질환 (349)
골질환 치료 (38)
당뇨병 (194)
백신 (181)
비만치료/다이어트 (44)
비처방 의약품 (152)
수의학 (17)
신경질환 (174)
신약개발 (1529)
암치료 (941)
약물전달 (185)
의약품 규제환경 (127)
정신질환 (86)
제네릭 의약품 (128)
제약회사분석 (523)
처방약 (165)
시장보고서

OTC Healthcare in Poland

리서치사 Euromonitor International
발행일 2009년 04월 상품코드 100728
페이지 정보 Tables 98
가격
US $ 2,400 ￦ 2,859,600 PDF by E-mail (Single User License)


영문목차

Abstract

Why buy this report

  • Get insight into trends in market performance
  • Pinpoint growth sectors and identify factors driving change
  • Identify market and brand leaders and understand the competitive environment

Product coverage

Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments

Executive summary

Increased spending on OTC drugs

Rising disposable incomes have helped to fuel demand for OTC drugs in Poland. An increasing number of consumers are able to afford specialised medicines such as medicated skin care, eye care, and dietary supplements. In addition, favourable media reports and intensive product advertising have also helped to fuel sales.

New innovative products fuel demand

The fact that Polish consumers are extremely open to trying new products means that manufacturers invest heavily in research and development and regularly launch new innovative brands, especially within saturated categories like analgesics and cough, cold and allergy remedies, where competition is particularly fierce.

Multinationals dominate sales

Multinational companies dominate OTC healthcare sales in Poland. The financial resources available to such companies allow them to run nation-wide advertising campaigns for their brands as well as to introduce new innovative products on a regular basis. The main multinational players in the segment are GlaxoSmithKline, Bayer, and Reckitt Benckiser.

Non-pharmacy channel sales continue to increase

The non-pharmacy channel continues to rise in importance due to growing demand amongst consumers for convenience as a result of the increasingly hectic pace of modern life.

Further growth expected

OTC healthcare is expected to continue to develop over the forecast period as there is still significant scope for further expansion. The fastest growth is expected to be recorded within categories such as digestive remedies which offer products that help fight stress-related disorders. In addition, consumers will spend more on preventative medicine such as vitamins and dietary supplements and products which help to improve one' s appearance such as medicated skin care.

Table of Contents

  • OTC HEALTHCARE IN POLAND : MARKET INSIGHT
  • EXECUTIVE SUMMARY
  • Increased spending on OTC drugs
  • New innovative products fuel demand
  • Multinationals dominate sales
  • Non-pharmacy channel sales continue to increase
  • Further growth expected
  • KEY TRENDS AND DEVELOPMENTS
  • Health and wellness trend increases in popularity
  • Self-medication increases in popularity
  • Lifestyle and environmental changes shape consumer behaviour
  • Innovations fuel growth
  • Increasing child-specific product sales
  • MARKET INDICATORS
    • Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
    • Table 2 Life Expectancy at Birth 2003-2008
  • MARKET DATA
    • Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
    • Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
    • Table 5 OTC Healthcare Company Shares by Value 2004-2008
    • Table 6 OTC Healthcare Brand Shares by Value 2005-2008
    • Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
    • Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
    • Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
    • Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
  • APPENDIX
  • OTC Registration and Classification
  • Vitamins & Dietary Supplements Registration and Classification
  • EU Legislation
  • Self-medication and Preventative Medicine
  • Generics
  • Re-classifications
    • Summary 1 OTC healthcare Switches 2005-2007
  • DEFINITIONS
    • Summary 2 Research Sources
  • LOCAL COMPANY PROFILES - POLAND
  • AFLOFARM FARMACJA POLSKA SP ZOO - OTC HEALTHCARE - POLAND
  • STRATEGIC DIRECTION
  • KEY FACTS
    • Summary 3 Aflofarm Farmacja Polska Sp zoo: Key Facts
    • Summary 4 Aflofarm Farmacja Polska Sp zoo: Operational Indicators
  • COMPANY BACKGROUND
  • PRODUCTION
    • Summary 5 Aflofarm Farmacja Polska Sp zoo: Production Statistics 2007
  • COMPETITIVE POSITIONING
    • Summary 6 Aflofarm Farmacja Polska Sp zoo: Competitive Position 2008
  • JELFA SA - OTC HEALTHCARE - POLAND
  • STRATEGIC DIRECTION
  • KEY FACTS
    • Summary 7 Jelfa SA: Key Facts
    • Summary 8 Jelfa SA: Operational Indicators
  • COMPANY BACKGROUND
  • PRODUCTION
    • Summary 9 Jelfa SA: Production Statistics 2007
  • COMPETITIVE POSITIONING
    • Summary 10 Jelfa SA: Competitive Position 2008
  • POLPHARMA SA - OTC HEALTHCARE - POLAND
  • STRATEGIC DIRECTION
  • KEY FACTS
    • Summary 11 Polpharma SA: Key Facts
    • Summary 12 Polpharma SA: Operational Indicators
  • COMPANY BACKGROUND
  • PRODUCTION
    • Summary 13 Polpharma SA: Production Statistics 2007
  • COMPETITIVE POSITIONING
    • Summary 14 Polpharma SA: Competitive Position 2008
  • POLSKI LEK SA - OTC HEALTHCARE - POLAND
  • STRATEGIC DIRECTION
  • KEY FACTS
    • Summary 15 Polski Lek SA: Key Facts
    • Summary 16 Polski Lek SA: Operational Indicators
  • COMPANY BACKGROUND
  • PRODUCTION
    • Summary 17 Polski Lek SA: Production Statistics 2007
  • COMPETITIVE POSITIONING
    • Summary 18 Polski Lek SA: Competitive Position 2008
  • PPF HASCO-LEK SA - OTC HEALTHCARE - POLAND
  • STRATEGIC DIRECTION
  • KEY FACTS
    • Summary 19 PPF Hasco-Lek SA: Key Facts
    • Summary 20 PPF Hasco-Lek SA: Operational Indicators
  • COMPANY BACKGROUND
  • PRODUCTION
    • Summary 21 PPF Hasco-Lek SA: Production Statistics 2007
  • COMPETITIVE POSITIONING
    • Summary 22 PPF Hasco-Lek SA: Competitive Position 2008
  • ANALGESICS IN POLAND
  • HEADLINES
  • TRENDS
  • RE-CLASSIFICATIONS
  • COMPETITIVE LANDSCAPE
  • PROSPECTS
  • SECTOR DATA
    • Table 11 Sales of Analgesics by Subsector: Value 2003-2008
    • Table 12 Sales of Analgesics by Subsector: % Value Growth 2003-2008
    • Table 13 Herbal vs Standard Topical Analgesics 2003-2008
    • Table 14 Topical Analgesics by Format: % Value Breakdown 2004-2008
    • Table 15 Analgesics Company Shares by Value 2004-2008
    • Table 16 Analgesics Brand Shares by Value 2005-2008
    • Table 17 Forecast Sales of Analgesics by Subsector: Value 2008-2013
    • Table 18 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013
  • COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN POLAND
  • HEADLINES
  • TRENDS
  • RE-CLASSIFICATIONS
  • COMPETITIVE LANDSCAPE
  • PROSPECTS
  • SECTOR DATA
    • Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
    • Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
    • Table 21 Sales of Decongestants by Type: Value 2003-2008
    • Table 22 Sales of Decongestants by Type: % Value Growth 2003-2008
    • Table 23 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
    • Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
    • Table 25 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
    • Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
    • Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
    • Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
    • Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013
  • DIGESTIVE REMEDIES IN POLAND
  • HEADLINES
  • TRENDS
  • RE-CLASSIFICATIONS
  • COMPETITIVE LANDSCAPE
  • PROSPECTS
  • SECTOR DATA
    • Table 30 Sales of Digestive Remedies by Subsector: Value 2003-2008
    • Table 31 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008
    • Table 32 Herbal vs Standard Digestive Remedies 2003-2008
    • Table 33 Digestive Remedies Company Shares by Value 2004-2008
    • Table 34 Digestive Remedies Brand Shares by Value 2005-2008
    • Table 35 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013
    • Table 36 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013
  • MEDICATED SKIN CARE IN POLAND
  • HEADLINES
  • TRENDS
  • RE-CLASSIFICATIONS
  • COMPETITIVE LANDSCAPE
  • PROSPECTS
  • SECTOR DATA
    • Table 37 Sales of Medicated Skin Care by Subsector: Value 2003-2008
    • Table 38 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
    • Table 39 Herbal vs Standard Medicated Skin Care 2003-2008
    • Table 40 Acne Treatments by Format: % Value Breakdown 2004-2008
    • Table 41 Medicated Skin Care Company Shares by Value 2004-2008
    • Table 42 Medicated Skin Care Brand Shares by Value 2005-2008
    • Table 43 Acne Treatments Brand Shares by Value 2005-2008
    • Table 44 Hair Loss Treatments Brand Shares by Value 2005-2008
    • Table 45 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
    • Table 46 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
  • VITAMINS AND DIETARY SUPPLEMENTS IN POLAND
  • HEADLINES
  • TRENDS - VITAMINS
  • TRENDS -- DIETARY SUPPLEMENTS
  • COMPETITIVE LANDSCAPE
  • PROSPECTS
  • SECTOR DATA
    • Table 47 Dietary Supplements: Brand Ranking by Positioning 2008
  • SECTOR DATA
    • Table 48 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008
    • Table 49 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
    • Table 50 Folic Acid v Other B Vitamins 2004-2008
    • Table 51 Dietary Supplements by Positioning 2006-2008
    • Table 52 Vitamins and Dietary Supplements Company Shares by Value 2004-2008
    • Table 53 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
    • Table 54 Vitamins Brand Shares by Value 2005-2008
    • Table 55 Dietary Supplements Brand Shares by Value 2005-2008
    • Table 56 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013
    • Table 57 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
  • NRT SMOKING CESSATION AIDS IN POLAND
  • HEADLINES
  • TRENDS
  • RE-CLASSIFICATIONS
  • COMPETITIVE LANDSCAPE
  • PROSPECTS
  • SECTOR INDICATORS
    • Table 58 Number of Smokers by Gender 2003-2008
  • SECTOR DATA
    • Table 59 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
    • Table 60 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
    • Table 61 NRT Gum Flavours: % Value Breakdown 2006-2008
    • Table 62 Smoking Cessation Aids Company Shares by Value 2004-2008
    • Table 63 Smoking Cessation Aids Brand Shares by Value 2005-2008
    • Table 64 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
    • Table 65 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013
  • EYE CARE IN POLAND
  • SECTOR DATA
    • Table 66 Sales of Eye Care by Subsector: Value 2003-2008
    • Table 67 Sales of Eye Care by Subsector: % Value Growth 2003-2008
    • Table 68 Standard Eye Care by Type: % Value Breakdown 2007-2008
    • Table 69 Eye Care Company Shares by Value 2004-2008
    • Table 70 Eye Care Brand Shares by Value 2005-2008
    • Table 71 Forecast Sales of Eye Care by Subsector: Value 2008-2013
    • Table 72 Forecast Sales of Eye Care by Subsector: % Value Growth 2008-2013
  • EAR CARE IN POLAND
  • SECTOR DATA
    • Table 73 Sales of Ear Care: Value 2003-2008
    • Table 74 Sales of Ear Care: % Value Growth 2003-2008
    • Table 75 Ear Care Company Shares by Value 2004-2008
    • Table 76 Ear Care Brand Shares by Value 2005-2008
    • Table 77 Forecast Sales of Ear Care: Value 2008-2013
    • Table 78 Forecast Sales of Ear Care: % Value Growth 2008-2013
  • ADULT MOUTH CARE IN POLAND
  • HEADLINES
  • SECTOR DATA
    • Table 79 Sales of Adult Mouth Care: Value 2003-2008
    • Table 80 Sales of Adult Mouth Care: % Value Growth 2003-2008
    • Table 81 Adult Mouth Care Company Shares by Value 2004-2008
    • Table 82 Adult Mouth Care Brand Shares by Value 2005-2008
    • Table 83 Forecast Sales of Adult Mouth Care: Value 2008-2013
    • Table 84 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
  • CALMING AND SLEEPING PRODUCTS IN POLAND
  • SECTOR DATA
    • Table 85 Sales of Calming and Sleeping Products: Value 2003-2008
    • Table 86 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
    • Table 87 Calming and Sleeping Products Company Shares by Value 2004-2008
    • Table 88 Calming and Sleeping Products Brand Shares by Value 2005-2008
    • Table 89 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
    • Table 90 Forecast Sales of Calming and Sleeping Products: % Value Growth 2008-2013
  • WOUND TREATMENTS IN POLAND
  • SECTOR DATA
    • Table 91 Sales of Wound Treatments by Subsector: Value 2003-2008
    • Table 92 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
    • Table 93 Wound Treatments Company Shares by Value 2004-2008
    • Table 94 Wound Treatments Brand Shares by Value 2005-2008
    • Table 95 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
    • Table 96 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013
  • OTC OBESITY IN POLAND
  • SECTOR DATA
    • Table 97 Forecast Sales of OTC Obesity: Value 2009-2013
    • Table 98 Forecast Sales of OTC Obesity: % Value Growth 2009-2013
  • EMERGENCY CONTRACEPTION IN POLAND
  • OVERVIEW
  • OTC TRIPTANS IN POLAND
  • OVERVIEW
Back to Top